Living reference work entry
This compound that acts against HAT (Human African trypanosomiasis) is now (2014) used within phase III clinical trials.
KeywordsClinical Trial Human African Trypanosomiasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Springer-Verlag Berlin Heidelberg 2015